Clinical outcomes of dexamethasone-eluting stent implantation in ST-elevation acute myocardial infarction

Catheterization and Cardiovascular Interventions

Volumn 70, Issue 4, 2007, Pages 492-497

  Jimenez Valero, Santiago ^a   Santos, Belen ^a   Pajin, Fernando ^a   Canton, Tomas ^a   Lazaro, Esther ^a   Moreu, Jose ^a   Hernandez, Gonzalo ^a   Padial, Luis Rodriguez ^a  

^a HOSPITAL VIRGEN DE LA SALUD   (Spain)

Author keywords

Dexamethasone; Inflammation; Myocardial infarction; Primary PCI; Stent

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; DEXAMETHASONE; TIROFIBAN;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD CLOT LYSIS; DEATH; DRUG ELUTING STENT; DRUG SAFETY; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART REINFARCTION; HEART VENTRICULOGRAPHY; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; REVASCULARIZATION; ST SEGMENT ELEVATION; STENT; THROMBOSIS; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTI-INFLAMMATORY AGENTS; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; DEXAMETHASONE; DRUG-ELUTING STENTS; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RECURRENCE; STROKE VOLUME; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 35348945977     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21131     Document Type: Article

References (38)

1. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz JS, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Ornato JP. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: A report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 2004;110:588-636.
2. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomized trials. Lancet 2003;361:13-20.
3. Stone GW, Grines GL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Carroll JD, Rutherford BD, Lansky AJ. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 2002;346:957-966.
4. Nordmann AJ, Hengstler P, Harr T, Young J, Bucher HC. Clinical outcomes of primary stenting versus balloon angioplasty in patients with myocardial infarction: A meta-analysis of randomized controlled trials. Am J Med 2004;116:253-262.
5. Grines CL, Cox DA, Stone GW, Garcia E, Mattos LA, Giambartolomei A, Brodie B, Madonna O, Eijgelshoven M, Lansky AJ, O'Neill WW, Morice MC. Coronary angioplasty with or without stent implantation for acute myocardial infarction: Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1999;341:1949-1956.
6. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE. Sirolimus-eluting stent versus standard stent in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323.
7. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenbeerg J, Popma JJ, Russell ME. A polymer based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-231.
8. Cohen MG, Ohman EM. Drug-eluting stents in myocardial infarction. Is science catching up with practice? JAMA 2005;293:2154-2156.
9. Lucas RA, Korol R, Pepine CJ. Inflammation in atherosclerosis. Some thoughts about acute coronary syndromes. Circulation 2006;113:e728-e732.
10. Corti R, Hutter R, Badimon JJ, Fuster V. Evolving concepts in the triad of atherosclerosis, inflammation and thrombosis. J Thromb Thrombolysis 2004;17:35-44.
11. Toutouzas K, Colombo A, Stefanadis C. Inflammation and restenosis after percutaneous coronary interventions. Eur Heart J 2004;25:1679-1687.
12. Liu X, Huang Y, Hanet C, Vandormael M, Legrand V, Dens J, et al. Study of antirestenosis with the BiodivYsio Dexamethasone-eluting stent (STRIDE). Catheter Cardiovasc Interv 2003;60:172-178.
13. Fuster V, Moreno PR, Fayad ZA, Corti R, Badimon JJ. Atherothrombosis and high risk plaque. Part I: Evolving concepts. J Am Coll Cardiol 2005;46:937-954.
14. Costa MA, Simon DI. Molecular basis of restenosis and drug-eluting stents. Circulation 2005;111:2257-2273.
15. Gaspardone A, Versaci F. Coronary stenting and inflammation. Am J Cardiol 2005;96 (Suppl):65L-70L.
16. Hojo Y, Ikeda U, Katsuki T, Mizuno O, Fukazawa H, Kurosaki K, Fujikawa H, Shimada K. Interleukin 6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis. Heart 2000;84:83-87.
17. Fukuda D, Shimada K, Tanaka A, Kawarabayashi T, Yoshiyama M, Yoshikawa J. Circulating monocytes and in-stent neointima after coronary stent implantation. J Am Coll Cardiol 2004;43: 18-23.
18. Gottsauner-Wolf M, Zasmeta G, Hornykewycz S, Nikfardjam M, Stepan E, Wexberg P, Zorn G, Probst P, Maaurer G, Huber K. Plasma levels of C-reactive protein after coronary stent implantation. Eur Heart J 2000;21:1152-1158.
19. Dibra A, Mehili J, Braun S, Hadamitzky M, Baum H, Dirschinger J, et al. Inflammatory response after intervention assesed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting. Am Heart J 2005;150:344-350.
20. Walter DH, Fichtischerer S, Sellwing M, Schachinger V, Zeiher AM. Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation. J Am Coll Cardiol 2001;37:839-846.
21. Mueller C, Buettner HJ, Hodgson JD, Marsch S, Perruchoud AP, Roskamm H, Neumann FJ. Inflammation and long-term mortality after non ST-elevation acute coronary syndromes treated with a very early invasive strategy in 1042 consecutive patients. Circulation 2002;105:1412-1415.
22. Liu X, De Scheerder I, Desmet W. Dexamethasone-eluting stent: An anti-inflammatory approach to inhibit coronary restenosis. Expert Rev Cardiovasc Ther 2004;2:653-660.
23. Versaci F, Gaspardone A, Tomai F, Ribichini F, Russo P, Proietti I, Ghini AS, Ferrero V, Chiarello L, Gioffre PA, Romeo F, Crea F. Immunosuppresive therapy for the prevention of restenosis after coronary artery stent implantation (IMPRESS Study). J Am Coll Cardiol 2002;40:1935-1942.
24. Patti G, Chello M, Pasceri V, Colonna D, Carminati P, Covino E, Di Sciascio G. Dexamethasone-eluting stents and plasma concentrations of adhesion molecules in patients with unstable coronary syndromes: Results of the historically controlled SESAME study. Clin Ther 2005;27:1411-1419.
25. Patti G, Pasceri V, Carminati P, D'Ambrosio A, Carcagni A, Di Sciascio G. Effect of dexamethasone-eluting stents on systemic inflammatory response in patients with unstable angina pectoris or recent myocardial infarction undergoing percutaneous coronary intervention. Am J Cardiol 2005;95:502-505.
26. Mut-Vitcu B, Dragulescu SI, Dragulescu A, El Kahlout A, Coroban A, Maximov D, Slovenski M. Inflammatory response after dexamethasone-eluting coronary stent implantation. Rom J Intern Med 2004;42:119-127.
27. Eisenberg MJ, Konnyu KJ. Review of randomized clinical trials of drug-eluting stents for the prevention of in-stent restenosis. Am J Cardiol 2006;98:375-382.
28. Lemos PA, Saia F, Hofma SH, Daemen J, Ong AT, Arampatzis CA, Hoye A, McFadden E, Sianos G, Smits PC, Van der Giessen WJ, De Feyter P, Van Domburg RT, Serruys PW. Short- and long-term clinical benefit of sirolimus-eluting stents compared with conventional bare stents for patients with acute myocardial infarction. J Am Coll Cardiol 2004;43:704-708.
29. Hofma SH, Ong AT, Aoki J, Van Mieghem AG, Rodriguez Granillo GA, Valgimigly M, Regar E, De Jaegere PT, McFadden E, Sianos G, Van der Giessen, De Feyter PJ, Van Domburg RT, Serruys PW. One year clinical follow up of paclitaxel-eluting stents for acute myocardial infarction compared with sirolimus-eluting stents. Heart 2005;91:1176-1180.
30. Cheneau E, Rha SW, Kuchulakanti PK, Stabile E, Kinnaird T, Torguson R, Pichard AD, Satler LF, Kent JM, Waksman R. Impact of sirolimus-eluting stents on outcomes of patients treated for acute myocardial infarction by primary angioplasty. Catheter Cardiovasc Interv 2005;65:469-472.
31. Newell MC, Henry CR, Sigakis CGJ, Unger B, Larson DM, Chavez IJ, Burke N, Traverse JH, Henry TD. Comparison of safety and eficacy of sirolimus-eluting stents versus bare metal stents in patients with ST-elevation myocardial infarction. Am J Cardiol 2006;97:1299-1302.
32. Reid Schwalm JD, Ahmad M, Velianou JL, Xie C, Natarajan MK. Primary and rescue percutaneous coronary intervention with paclitaxel-eluting stent implantation in ST-elevation myocardial infarction. Am J Cardiol 2006;97:1308-1310.
33. Percoco G, Manari A, Guastaroba P, Campo G, Guiducci V, Aurier E, Sangiorgio P, Passerini F, Geraci G, Piovaccari G, Naldi M, Saia F, Marzocchi A. Safety and long-term efficacy of sirolimus-eluting stent in ST-elevation acute myocardial infarction: The REAL Registry. Cardiovasc Drugs Ther 2006;20:63-68.
34. Valgimigly M, Percoco G, Malagutti P, Campo G, Ferrari F, Barbieri D, Cicchitelli G, McFadden EP, Merlini F, Ansani L, Guardigli G, Bettini A, Parrinello G, Boersma E, Ferrari R. Tirofiban and sirolimus-eluting stents versus abciximab and bare-metal stent for acute myocardial infarction. A randomized trial. JAMA 2005;293:2109-2117.
35. Mc Fadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, Suddath W, Weissman NJ, Torguson R, Kent KM, Pichard AD, Satler LF, Waksman R, Serruys PW. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004;364:1519-1521.
36. Park DW, Park SW, Park KH, Le BK, Kim YH, Lee CW, Hong MK, Kim JJ, Park SJ. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Am J Cardiol 2006;98:352-356.
37. Spaulding S, Henry P, Teiger E, Beatt K, Bramucci E, Carrié D, Slama MS, Merkely B, Erglis A, Margheri M, Varenne O, Cebrian A, Stoll HP, Snead DB, Bode C. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 2006;355:1093-1104.
38. Laarman GJ, Suttorp MJ, Dirksen MT, Van Heerebeek L, Kiemeneij F, Slagboom T, Van der Wieken LR, Tijsen J, Rensing BJ, Patterson M. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med 2006;355:1105-1113.